RANI — RANI THERAPEUTICS HLDGS INC

Ownership history in LASRY MARC  ·  15 quarters on record

This page tracks every 13F SEC filing in which LASRY MARC reported a position in RANI THERAPEUTICS HLDGS INC (RANI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.16% (2022 Q3)
Avg. % of fund
0.45%
First filed
2022 Q1
Last filed
2025 Q3
Quarters held
15
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 62,887 — 0% 0.21% $31.4M $0.50
2025 Q2 UNCHANGED 62,887 — 0% 0.18% $32.3M $0.51
2025 Q1 UNCHANGED 62,887 — 0% 0.36% $79.2M $1.26
2024 Q4 UNCHANGED 62,887 — 0% 0.38% $86.2M $1.37
11 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RANI price (monthly, adj. close)

Other funds also holding RANI

As of 2025 Q4 — sorted by position size

Samsara BioCapital, LLC 3Y 7Y 1.18% AWM Investment Company, Inc. 3Y 7Y 0.85% Nan Fung Group Holdings Ltd 3Y 0.6% Longaeva Partners L.P. 0.24% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.12% Siren, L.L.C. 0.08% 683 Capital Management, LLC 3Y 7Y 0.03% UNITED SERVICES AUTOMOBILE ASSOCIATION 3Y 7Y 0.03% Well Done, LLC 3Y 7Y 0.01% ACT Advisors, LLC. 3Y 0.01%
← Back to LASRY MARC Holdings